C4 Therapeutics, Inc. CCCC
NASDAQ · United States · Health Technology
$2.95-0.19 (-6.05%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.18 | -0.23 | +20.5% | $6.64M | +66.0% | +7.7%$3.62→$3.90 |
| Q1 2026 | 2026-05-12 | -0.20 | -0.26 | +23.1% | — | — | +16.1%$3.17→$3.68 |
| Q4 2025 | 2026-02-26 | -0.18 | -0.39 | +53.8% | — | — | -2.5%$2.77→$2.70 |
| Q3 2025 | 2025-11-06 | -0.44 | -0.47 | +6.4% | — | — | -1.3%$2.37→$2.34 |
| Q4 2024 | 2025-02-27 | -0.49 | -0.45 | -8.9% | — | — | — |
| Q3 2024 | 2024-10-31 | -0.35 | -0.33 | -6.1% | — | — | — |
| Q4 2023 | 2024-02-22 | -0.68 | -0.69 | +1.4% | — | — | — |
| Q3 2023 | 2023-11-01 | -0.54 | -0.65 | +16.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.